Desensitization to biological agents used in rheumatology

Biological agents such as monoclonal antibodies and fusion proteins are widely used for the treatment of patients with various rheumatic disorders, influencing the quality of life, disability and even mortality in patients. However, biological agents can evoke adverse reactions of different grades o...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joanna Makowska, Anna Lewandowska-Polak
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2020
Materias:
R
Acceso en línea:https://doaj.org/article/4a98b33c825846228dec3147539a23bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!